Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest updates to the Moderna Press Releases page
- Check6 days agoChange DetectedThe press releases list entries (including specific dated titles) were removed, and the page now shows only the loading/selector behavior rather than those items.SummaryDifference6%
- Check13 days agoChange DetectedThe press releases listing on the News page is no longer visible and is replaced by a loading indicator. The previous content listing is not shown.SummaryDifference6%
- Check20 days agoChange DetectedAdded a new press release entry for ESCMID 2026: 'Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA' (April 6, 2026). Removed the earlier press release about Moderna's collaboration with Recordati on mRNA-3927 (January 29, 2026).SummaryDifference1%
- Check28 days agoChange DetectedNew 2026 press releases and dates are added to the News and Blog Posts section (e.g., Moderna Resolves Global Patent Litigation with Arbutus/Genevant, Feb–Mar 2026). Several navigation items, including About Us and Stock Info, were removed.SummaryDifference11%
- Check35 days agoChange DetectedStock price and trading volume were updated on the page. A large portion of press releases and related navigation items appear to have been removed.SummaryDifference6%
- Check42 days agoChange DetectedHeader stock ticker updated from NASD: MRNA $55.80 Vol: 4.57M to NASD: MRNA $52.37 Vol: 5.51M.SummaryDifference0.5%
Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.